FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease and other cognitive issues when they have the symptoms of the conditions. It ...

Share on Pinterest Scientists are getting closer to accurately and quickly diagnosing chronic fatigue syndrome. Santi Nuñez/Stocksy There is no single test to diagnose chronic fatigue syndrome (CFS), ...

Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME/CFS). The ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...

Scientists in the United Kingdom say they have developed a blood test that can diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with 96% accuracy—the first of its kind. For many ...

Emory researchers discovered blood changes that could allow Alzheimer’s to be detected years before symptoms appear. The team is developing a blood test that may identify early risk and guide ...

The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The “Elecsys pTau181 test” measures pTau181 protein levels in human plasma which ...